首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢传输型便秘中医证型与血管活性肠肽和P物质关系
引用本文:李 明,王建民,杨玲玲,王乐伟.慢传输型便秘中医证型与血管活性肠肽和P物质关系[J].安徽中医学院学报,2014,33(5):21-23.
作者姓名:李 明  王建民  杨玲玲  王乐伟
作者单位:1. 安徽中医药大学第一附属医院肛肠科,安徽合肥,230031
2. 安徽中医药大学研究生部,安徽合肥,230038
基金项目:安徽高校省级优秀青年基金项目(2012SQRL110);安徽中医学院临床科研基金项目(2010LC-035A);安徽中医学院青年科研基金项目(2011QN023)
摘    要:目的探究慢传输型便秘(slow transit constipation,STC)中医证型与血管活性肠肽(vasoactive intestinal peptide,VIP)、P物质(substance P,SP)的关系,为中医辨证客观化寻找证据。方法纳入肠道实热证、肠道气滞证、肺脾气虚证、脾肾阳虚证、津亏血少证STC患者各15例,另随机选取15例健康人作为对照组。应用酶联免疫吸附双抗体夹心法检测血清VIP、SP水平。结果 STC患者血清VIP和SP水平显著高于对照组(P0.05,或P0.01);STC虚证患者血清VIP和SP水平显著高于STC实证患者(P0.01);3种虚证(肺脾气虚证、脾肾阳虚证、津亏血少证)患者血清VIP及SP水平比较,以及2种实证(肠道实热证、肠道气滞证)患者血清VIP水平比较,差异均无统计学意义(P0.05);肠道气滞证患者血清SP水平显著低于肠道实热证(P0.05)。结论血清VIP、SP水平与STC中医证型有关,有利于鉴别STC虚证和实证。

关 键 词:慢传输型便秘  中医证型  血管活性肠肽  P物质

Relationship of Traditional Chinese Medicine Syndrome Types with Vasoactive Intestinal Peptide and Substance P in Patients with Slow Transit Constipation
LI Ming , WANG Jian-min , YANG Ling-ling , WANG Le-wei.Relationship of Traditional Chinese Medicine Syndrome Types with Vasoactive Intestinal Peptide and Substance P in Patients with Slow Transit Constipation[J].Journal of Anhui Traditional Chinese Medical College,2014,33(5):21-23.
Authors:LI Ming  WANG Jian-min  YANG Ling-ling  WANG Le-wei
Institution:1.Department of Coloproctology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Anhui Hefei 230031, China; 2. Graduate Division, Anhui University of Chinese Medicine, Anhui Hefei 230038, China
Abstract:Objective To investigate the relationship of traditional Chinese medicine (TCM) syndrome types with vasoactive intestinal peptide (VIP) and substance P (SP) in patients with slow transit constipation (STC) and to provide evidence for TCM syndrome differentiation. Methods STC patients with syndrome of excessive heat in intestine, syndrome of qi stagnation in intestine, syndrome of lung spleen qi deficiency, syndrome of spleen kidney yang deficiency, and syndrome of fluid depletion and blood deficiency (15 cases for each syndrome), as well as 15 randomly selected healthy controls (as control group), were included in the study. Double antibody sandwich enzyme linked immunosorbent assay was used to determine serum VIP and SP levels. Results The STC patients had significantly higher serum VIP and SP levels than the control group (P<0.05 or P<0.01). The STC patients with deficiency syndromes had significantly higher serum VIP and SP levels than those with excess syndromes (P<0.01). Serum VIP and SP levels showed no significant differences between patients with syndrome of lung spleen qi deficiency, syndrome of spleen kidney yang deficiency, and syndrome of fluid depletion and blood deficiency (P>0.05), and serum VIP level showed no significant difference between patients with syndrome of excessive heat in intestine and syndrome of qi stagnation in intestine (P>0.05). Serum SP level was significantly lower in patients with syndrome of qi stagnation in intestine than in those with syndrome of excessive heat in intestine (P<0.05). Conclusion Serum VIP and SP levels are related to the TCM syndrome types of STC and are useful for differentiation between deficiency syndrome and excess syndrome in STC patients.
Keywords:slow transit constipation  traditional Chinese medicine syndrome type  vasoactive intestinal peptide  substance P
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《安徽中医学院学报》浏览原始摘要信息
点击此处可从《安徽中医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号